---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-206427"
form_type: "8-K"
ticker: "AMWL"
cik: "0001393584"
company_name: "American Well Corp"
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:18:34.624852+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Amwell beats Q1 revenue guidance at $54.9M; net loss narrows to $10.3M

## Summary
- Q1 revenue $54.9M exceeds guidance; subscription $24.9M, AMG visit revenue $28.9M.
- Net loss improved to ($10.3M) from ($25.2M) in Q4 2025; gross margin 51%.
- Adjusted EBITDA loss narrowed to ($3.1M) from ($10.3M) in Q4 2025.
- FY2026 guidance reaffirmed: revenue $195-205M, Adj EBITDA ($16M)-($12M); Q2 rev $48-52M.
- Reiterates goal of positive cash flow from operations in Q4 2026.

## SEC filing metadata
- accession: 0001193125-26-206427
- form_type: 8-K
- ticker: AMWL
- cik: 0001393584
- company_name: American Well Corp
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393584/000119312526206427/0001193125-26-206427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393584/000119312526206427/amwl-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-206427
- JSON: https://secwatch.observer/filing/0001193125-26-206427.json
- Plain text: https://secwatch.observer/filing/0001193125-26-206427.txt

## Source-grounded claims
- claim_id: 2ecfe00f18609e25096a789babaff50e07fc8966
  claim: American Well Corp reported Q2 2026 results: revenue $48- $52 million. Guidance initiated.
  evidence_excerpt: The company also provided financial guidance for Q2 2026 Revenue and adjusted EBITDA: • Q2 revenue in the range of $48- $52 million • Q2 adjusted EBITDA in the range of ($4) – ($2) million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393584/000119312526206427/0001193125-26-206427-index.htm
- claim_id: 609341cb8213e4cf53537c8e2da7735db39759c7
  claim: American Well Corp reported Q1 2026 results: revenue Recorded Total Revenue of $54.9 million, net income Net loss was ($10.3) million.
  evidence_excerpt: Recorded Total Revenue of $54.9 million exceeding the previously provided financial guidance for Q1 o Achieved subscription revenue of $24.9 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $28.9 million • Reported gross margin of 51% • Net loss was ($10.3) million, compared to ($25.2) million in fourth quarter of 2025, continuously moving from quarter to quarter in a favorable trajectory
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393584/000119312526206427/0001193125-26-206427-index.htm
- claim_id: d2a199130c5cfcae8861ca3690513c07b50b3ad4
  claim: American Well Corp reported 2026 full year results: revenue $195 to $205 million. Guidance reaffirmed.
  evidence_excerpt: The company reaffirmed its 2026 revenue and AMG visits guidance and updated its Adjusted EBITDA outlook: • Revenue in the range of $195 to $205 million • AMG visits between 1.32 and 1.37 million • Adjusted EBITDA in the range of between ($16) million to ($12) million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393584/000119312526206427/0001193125-26-206427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.